07:00 , Apr 6, 2015 |  BioCentury  |  Finance

Fundamental rally

2Q15 Financial Markets Preview Following three consecutive years of spectacular returns and a solid first quarter, bankers and buysiders remain confident that large caps will continue to deliver on sales and smaller companies will continue...
07:00 , Mar 23, 2015 |  BC Week In Review  |  Financial News

CollabRx financial update

CollabRx Inc. (NASDAQ:CLRX), San Francisco, Calif.   Business: Bioinformatics   Date announced: 2015-03-03   Note: CollabRx raised $450,000 through the sale of 354,330 shares at $1.27 to cover the overallotment from its Feb. 25 follow-on,...
08:00 , Mar 2, 2015 |  BC Week In Review  |  Financial News

CollabRx Inc completes follow-on

CollabRx Inc . (NASDAQ:CLRX), San Francisco, Calif.   Business: Bioinformatics   Date completed: 2015-02-25   Type: Follow-on   Raised: $3 million   Shares: 2.4 million   Price: $1.27   Shares after offering: 9.1 million  ...
08:00 , Feb 23, 2015 |  BC Week In Review  |  Financial News

CollabRx Inc completes follow-on

CollabRx Inc . (NASDAQ:CLRX), San Francisco, Calif.   Business: Bioinformatics   Date completed: 2015-02-19   Type: Follow-on   Raised: $4.8 million   Shares: 3.8 million   Price: $1.25   Shares after offering: 6.8 million  ...
07:00 , Mar 10, 2014 |  BC Week In Review  |  Company News

CollabRx management update

CollabRx Inc. (NASDAQ:CLRX), San Francisco, Calif.   Business: Bioinformatics   Hired: Clifford Baron as VP and COO, formerly director of biology product marketing, business development and professional services at Accelrys Inc.  ...
08:00 , Jan 27, 2014 |  BC Week In Review  |  Company News

CollabRx, Cynvenio Biosystems sales and marketing update

CollabRx launched its Therapy Finder for breast cancer patients who order Cynvenio's ClearID testing services. The launch extends the scope of a December deal to pair the CollabRx Genetic Variant Annotation (GVA) Service with tumor...
08:00 , Jan 6, 2014 |  BC Week In Review  |  Financial News

CollabRx financial update

CollabRx filed a shelf registration covering the sale of up to $10 million of its common stock. The company, which closed Friday at $3.85, has 2 million shares outstanding. CollabRx Inc. (NASDAQ:CLRX), San Francisco, Calif....
08:00 , Dec 23, 2013 |  BC Week In Review  |  Company News

CollabRx, Cynvenio Biosystems deal

CollabRx will provide clinical interpretation for Cynvenio's ClearID and LiquidBiopsy genomic testing services. Cynvenio will have access to multiple CollabRx products, including the Genetic Variant Annotation (GVA) Service, which provides information on the clinical impact...
07:00 , Sep 9, 2013 |  BC Week In Review  |  Company News

CollabRx management update

CollabRx Inc. (NASDAQ:CLRX), San Francisco, Calif.   Business: Bioinformatics   Transitioned: George Lundberg to CMO, while remaining editor-in-chief and chair of the editorial advisory board  ...
07:00 , Apr 15, 2013 |  BC Week In Review  |  Company News

CollabRx Inc., Sengenics International Pte. Ltd. deal

The companies partnered to use CollabRx's technology and content resources with Sengenics' molecular cancer exome sequencing tests and reports. Sengenics will create a comprehensive medical informatics solution pairing its test results with CollabRx's knowledge on...